Schlech BA[au] - Search Results

Year	Number of Results
1969	1
1975	2
1981	1
1982	1
1983	1
1984	1
1985	1
1995	1
2000	1
2001	1
2002	1
2003	3
2004	2
2005	5
2006	2
2023	0

1

Phospholipids of Azotobacter vinelandii.

Jurtshuk P, Schlech BA. Jurtshuk P, et al. Among authors: schlech ba. J Bacteriol. 1969 Mar;97(3):1507-8. doi: 10.1128/jb.97.3.1507-1508.1969. J Bacteriol. 1969. PMID: 5776538 Free PMC article.

2

Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

Schlech BA, Alfonso E. Schlech BA, et al. Surv Ophthalmol. 2005 Nov;50 Suppl 1:S7-15. doi: 10.1016/j.survophthal.2005.05.002. Surv Ophthalmol. 2005. PMID: 16257313 Review.

3

Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

Schlech BA, Blondeau J. Schlech BA, et al. Surv Ophthalmol. 2005 Nov;50 Suppl 1:S64-7. doi: 10.1016/j.survophthal.2005.05.005. Surv Ophthalmol. 2005. PMID: 16257312 Review.

4

Review of standard for evaluating the effectiveness of contact lens disinfectants.

Rosenthal RA, Sutton SV, Schlech BA. Rosenthal RA, et al. Among authors: schlech ba. PDA J Pharm Sci Technol. 2002 Jan-Feb;56(1):37-50. PDA J Pharm Sci Technol. 2002. PMID: 11865782 Review.

5

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

Robertson SM, Curtis MA, Schlech BA, Rusinko A, Owen GR, Dembinska O, Liao J, Dahlin DC. Robertson SM, et al. Among authors: schlech ba. Surv Ophthalmol. 2005 Nov;50 Suppl 1:S32-45. doi: 10.1016/j.survophthal.2005.07.001. Surv Ophthalmol. 2005. PMID: 16257309 Review.

6

In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.

Stroman DW, Dajcs JJ, Cupp GA, Schlech BA. Stroman DW, et al. Among authors: schlech ba. Surv Ophthalmol. 2005 Nov;50 Suppl 1:S16-31. doi: 10.1016/j.survophthal.2005.06.002. Surv Ophthalmol. 2005. PMID: 16257308 Review.

7

Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature.

Buck SL, Rosenthal RA, Schlech BA. Buck SL, et al. Among authors: schlech ba. CLAO J. 2000 Apr;26(2):72-84. CLAO J. 2000. PMID: 10810937 Review.

8

Amoebicidal activity of multipurpose contact lens solutions.

Buck SL, Rosenthal RA, Schlech BA. Buck SL, et al. Among authors: schlech ba. Eye Contact Lens. 2005 Mar;31(2):62-6. doi: 10.1097/01.icl.0000146322.63546.50. Eye Contact Lens. 2005. PMID: 15798475

9

Clinical and epidemiological advantages of culturing bacterial keratitis.

Wilhelmus KR, Schlech BA. Wilhelmus KR, et al. Among authors: schlech ba. Cornea. 2004 Jan;23(1):38-42. doi: 10.1097/00003226-200401000-00007. Cornea. 2004. PMID: 14701956

10

Efficacy of myristamidopropyl dimethylamine (Aldox) against corneal isolates of Acanthamoeba spp.

Schuster FL, Buck S, Rosenthal RA, Schlech BA. Schuster FL, et al. Among authors: schlech ba. J Eukaryot Microbiol. 2003;50 Suppl:520-1. doi: 10.1111/j.1550-7408.2003.tb00616.x. J Eukaryot Microbiol. 2003. PMID: 14736149 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results